Insider Transactions in Q3 2022 at Viracta Therapeutics, Inc. (VIRX)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 26
2022
|
Lisa Rojkjaer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,190
-4.73%
|
$8,760
$4.01 P/Share
|
|
Aug 26
2022
|
Ivor Royston |
SELL
Open market or private sale
|
Direct |
13,379
-2.14%
|
$53,516
$4.01 P/Share
|
|
Aug 26
2022
|
Daniel R. Chevallard CFO and COO |
SELL
Open market or private sale
|
Direct |
3,655
-4.25%
|
$14,620
$4.02 P/Share
|
|
Aug 25
2022
|
Lisa Rojkjaer Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,127
+8.18%
|
-
|
|
Aug 25
2022
|
Ivor Royston |
BUY
Exercise of conversion of derivative security
|
Direct |
25,219
+3.87%
|
-
|
|
Aug 25
2022
|
Roger Pomerantz |
BUY
Exercise of conversion of derivative security
|
Direct |
9,034
+16.67%
|
-
|
|
Aug 25
2022
|
Daniel R. Chevallard CFO and COO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,889
+7.41%
|
-
|